Safety and clinical activity of atezolizumab in head and neck cancer: results from a phase I trial. - Colevas, A D; Bahleda, R; Braiteh, F; Balmanoukian, A; Brana, I; Chau, N G; Sarkar, I; Molinero, L; Grossman, W; Kabbinavar, F; Fassò, M; O'Hear, C; et al. (Annals of Oncology, 2018)